puromycin aminonucleoside and Disease Exacerbation

puromycin aminonucleoside has been researched along with Disease Exacerbation in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Z; Fan, Y; Liu, Z; Shi, S; Wu, J; Zen, K; Zeng, C; Zhang, C; Zhong, Y1
Fukusumi, Y; Kawachi, H; Kayaba, M; Kitazawa, Y; Takahashi, A; Tomita, M; Yamazaki, M1
Bailey, S; Brown, T; Carraher, D; Homer, BL; Li, Y; Li, Z; Mathur, S; Nassirpour, R; O'Neil, SP; Percival, K; Warneke, J; Whiteley, LO1
Brinkkoetter, PT; Krofft, RD; Logar, CM; Pippin, JW; Shankland, SJ1
Magil, A1
Granados-Silvestre, MD; Hernández-Pando, R; Medina-Campos, ON; Pedraza-Chaverri, J1
Bastacky, S; Jackso, EK; Kost, CK; Rominski, BR; Tofovic, SP1

Other Studies

7 other study(ies) available for puromycin aminonucleoside and Disease Exacerbation

ArticleYear
Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
    The Journal of pathology, 2014, Volume: 234, Issue:2

    Topics: Acute Kidney Injury; Animals; Apoptosis; Autophagy; Disease Models, Animal; Disease Progression; Female; Glomerulosclerosis, Focal Segmental; Humans; Male; Podocytes; Proteinuria; Puromycin Aminonucleoside; Rats, Wistar

2014
Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin.
    Journal of nephrology, 2014, Volume: 27, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Disease Models, Animal; Disease Progression; Female; Gene Expression Regulation; Intracellular Signaling Peptides and Proteins; Irbesartan; Kidney Glomerulus; Membrane Proteins; Nephrosis, Lipoid; Proteinuria; Puromycin Aminonucleoside; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors

2014
Identification of Promising Urinary MicroRNA Biomarkers in Two Rat Models of Glomerular Injury.
    Toxicological sciences : an official journal of the Society of Toxicology, 2015, Volume: 148, Issue:1

    Topics: Acute Kidney Injury; Animals; Biomarkers; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Glomerulonephritis, Membranous; Heymann Nephritis Antigenic Complex; Immune Sera; Kidney Glomerulus; Laser Capture Microdissection; Male; Metabolomics; MicroRNAs; Microscopy, Electron, Transmission; Oxidative Stress; Podocytes; Puromycin Aminonucleoside; Rats, Sprague-Dawley; Sheep, Domestic

2015
Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo.
    Kidney international, 2007, Volume: 72, Issue:4

    Topics: Animals; Antibodies; Apoptosis; Autoantibodies; Cell Proliferation; Cells, Cultured; Darbepoetin alfa; Disease Models, Animal; Disease Progression; Erythropoietin; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Janus Kinase 2; Mice; Podocytes; Protective Agents; Proteinuria; Proto-Oncogene Proteins c-akt; Puromycin Aminonucleoside; Receptors, Erythropoietin; Signal Transduction; Transforming Growth Factor beta1; Ultraviolet Rays

2007
Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant.
    Journal of the American Society of Nephrology : JASN, 1996, Volume: 7, Issue:11

    Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Chronic Disease; Disease Models, Animal; Disease Progression; Follow-Up Studies; Immunohistochemistry; Infusions, Intravenous; Kidney Glomerulus; Lipid Metabolism; Male; Nephrotic Syndrome; Probucol; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley

1996
Effect of the in vivo catalase inhibition on aminonucleoside nephrosis.
    Free radical biology & medicine, 1999, Volume: 27, Issue:3-4

    Topics: Amitrole; Animals; Catalase; Disease Progression; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glutathione Peroxidase; Male; Nephrosis; Puromycin Aminonucleoside; Rats; Rats, Wistar; Reactive Oxygen Species

1999
Caffeine augments proteinuria in puromycin-aminonucleoside nephrotic rats.
    Renal failure, 2000, Volume: 22, Issue:2

    Topics: Animals; Caffeine; Creatinine; Disease Progression; Drug Synergism; Kidney Cortex; Kidney Failure, Chronic; Kidney Function Tests; Male; Nephrosis; Phosphodiesterase Inhibitors; Proteinuria; Purinergic P1 Receptor Antagonists; Puromycin Aminonucleoside; Random Allocation; Rats; Rats, Sprague-Dawley; Renin

2000